[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
October 15, 2008

Escitalopram, Problem-Solving Therapy, and Poststroke Depression

JAMA. 2008;300(15):1757-1759. doi:10.1001/jama.300.15.1757-b

To the Editor: The study of prevention of poststroke depression by Dr Robinson and colleagues1 showed modest clinical effects of the SSRI escitalopram given over 12 months compared with placebo and problem-solving therapy. However, comparing the design of this study and its positive results with another poststroke depression study of the same group with negative results2 raises important questions.

First Page Preview View Large
First page PDF preview
First page PDF preview
×